Subscribe to RSS
DOI: 10.1055/s-2007-977419
A Versatile Synthetic Approach to Isoguanine Derivatives
Publication History
Publication Date:
03 April 2007 (online)
Abstract
5-Amino-4-(N-ethoxycarbonyl)formamidino imidazoles were prepared from 5-amino-4-(N-ethoxycarbonyl)cyanoformimidoyl imidazoles and primary alkyl amines, under mild experimental conditions. The product imidazoles were selectively cyclized to N 6-substituted isoguanines by reflux in acetonitrile with one equivalent of sulfuric acid, followed by neutralization. The same imidazoles led to N 1-alkylisoguanines as the major product upon reflux in ethanol.
Key words
heterocycles - rearrangements - ring closure - imidazole - isoguanine
- 1 For a recent review, see:
Legraverend M.Grierson DS. Bioorg. Med. Chem. 2006, 14: 3987 -
2a
Farooqi AHA.Shukla YN.Shukla A.Bhakuni DS. Phytochemistry 1990, 29: 2061 -
2b
Dahiya JS.Tewari JP. Phytochemistry 1991, 30: 2825 -
2c
Fujii T.Ohba M.Kawamura H.Haneishi T.Matsubara S. Chem. Pharm. Bull. 1993, 41: 1362 -
3a
Hecht SM.Leonard NJ.Schmitz RY.Skoog F. Phytochemistry 1974, 13: 329 -
3b
Chen C.-M.Smith OC.McChesney JD. Biochemistry 1975, 14: 3088 -
4a
Yamazaki A.Okutsu M.Yamada Y. Nucleic Acids Res. 1976, 3: 251 -
4b
Yamazaki A.Okutsu M. J. Heterocycl. Chem. 1978, 15: 353 -
4c
Chern J.-W.Lee H.-Y.Huang M.Shish FJ. Tetrahedron Lett. 1987, 28: 2151 - 5
Yamazaki A.Kumashiro I.Takenishi T.Ikehara M. Chem. Pharm. Bull. 1968, 2172 - 6
Davoll J. J. Am. Chem. Soc. 1951, 73: 3174 - 7
Cramer F.Schlingloff G. Tetrahedron Lett. 1964, 13: 3201 - 8
Nair V.Young DA. J. Org. Chem. 1985, 50: 406 - 9
Divakar KJ.Mottahedeh M.Reese CB.Sanghvi YS.Swift KAD. J. Chem. Soc., Perkin Trans. 1 1991, 771 - 10
De Napoli L.Montesarchio D.Piccialli G.Santacroce C.Varra M. J. Chem. Soc., Perkin Trans. 1 1995, 15 -
11a
Fuhrman FA.Fuhrman GJ.Kim YH.Pavelka LA.Moshee HS. Science 1980, 207: 193 -
11b
Quinn RJ.Gregson RP.Cook AF.Bartlett RT. Tetrahedron Lett. 1980, 21: 567 -
11c
Cook AF.Bartlett RT.Gregson RP.Quinn RJ. J. Org. Chem. 1980, 45: 4020 -
12a
Baird-Lambert J.Marwood JF.Davies LP.Taylor KM. Life Sci. 1980, 26: 1069 -
12b
Davies LP.Taylor KM.Gregson RP.Quinn RJ. Life Sci. 1980, 26: 1079 -
12c
Davies LP.Cook AF.Poonian MS.Taylor KM. Life Sci. 1980, 26: 1089 -
13a
Grozinger K.Freter KR.Farina P.Gladczuk A. Eur. J. Med. Chem. 1983, 18: 221 -
13b
Nachman RJ.
J. Heterocycl. Chem. 1985, 22: 953 -
13c
Grozinger KG.Onan KD. J. Heterocycl. Chem. 1986, 23: 737 - 14
Bartlett RT.Cook AF.Holman MJ.McComas WW.Nowoswait EF.Poonian MS. J. Med. Chem. 1981, 24: 947 -
15a
Alves MJ.Booth BL.Freitas AP.Proença MF. J. Chem. Soc., Perkin Trans. 1 1992, 913 -
15b
Booth BL.Dias AM.Proença MF. J. Chem. Soc., Perkin Trans. 1 1992, 2119 -
15c
Alves MJ.Booth BL.Proença MF.
J. Heterocycl. Chem. 1994, 31: 345 -
15d
Booth BL.Coster RD.Proença MF. Synthesis 1988, 389 -
15e
Alves MJ.Booth BL.Carvalho MA.Pritchard RG.Proença MF. J. Heterocycl. Chem. 1997, 739 -
15f
Al-Azmi A.Booth BL.Carpenter RA.Carvalho MA.Marrelec E.Pritchard RG.Proença MF. J. Chem. Soc., Perkin Trans. 1 2001, 2532 -
15g
Booth BL.Cabral IM.Dias AM.Freitas AP.Matos-Beja AM.Proença MF.Ramos-Silva M. J. Chem. Soc., Perkin Trans. 1 2001, 1241 -
15h
Carvalho MA.Esteves TM.Proença MF.Booth BL. Org. Biomol. Chem. 2004, 2: 1019 -
15i
Carvalho MA.Álvares Y.Zaki ME.Proença MF.Booth BL. Org. Biomol. Chem. 2004, 2: 2340 -
16a
Dias AM.Cabral IM.Proença MF.Booth BL. J. Org. Chem. 2002, 67: 5546 -
16b
Zaki ME.Proença MF.Booth BL. J. Org. Chem. 2003, 68: 276
References and Notes
Compounds 3
Aqueous methylamine (for 3a and 3b, 14 equiv), or benzylamine (for 3c and 3d, 2-3 equiv) was added to a suspension of imidazole 2 in CH2Cl2 (for 3a and 3b), EtOH (for 3c), or MeCN (for 3d, 2-12 mL). The mixture was stirred at r.t. for 10 min to 18 h. The product precipitated from the reaction mixture (3c and 3d) or the solvent was removed in the rotary evaporator (3a and 3b) and EtOH was added to the residue. The white solid was filtered and washed with EtOH (3a-c), or MeCN(3d), and Et2O. The structure of the products obtained was confirmed by elemental analysis, 1H NMR and 13C NMR spectroscopy.
Characterization of 3a
1H NMR (300 MHz, DMSO-d
6, 20 °C): δ (mixture of conformers A and B, ratio A/B = 3:2) = 9.90 (br s, 1 H, A), 8.00 (br s, 1 H, B), 7.40 (d, J = 9.0 Hz, 2 H), 7.39 (s, 1 H), 7.12 (d, J = 9.0 Hz, 2 H), 6.94 (br s, 2 H, A), 5.98 (br s, 2 H, B), 3.97 (q, J = 7.2 Hz, 2 H), 3.81 (s, 3 H), 3.41 (s, 3 H, A), 2.74 (s, 3 H, B), 1.17 (t, J = 7.2 Hz, 3 H); 1H NMR (300 MHz, DMSO-d
6, 50 °C): δ (only one set of bands is present) = 10.20-9.20 (br s, 1 H), 7.37 (d, J = 8.7 Hz, 2 H), 7.34 (s, 1 H), 7.11 (d, J = 8.7 Hz, 2 H), 6.80-6.30 (br s, 2 H), 3.99 (q, J = 7.2 Hz, 2 H), 3.82 (s, 3 H), 3.20 (s, 3 H), 1.18 (t, J = 7.2 Hz, 3 H). 13C NMR (75 MHz, DMSO-d
6): δ = 163.49 (br, A), 159.20, 156.80 (br, B), 147.08 (br), 142.70, 130.99, 126.91, 126.72, 114.99, 110.00-114.00 (br), 59.47 (br), 55.55, 32.31 (br, A), 23.45 (br, B), 14.68. Anal. Calcd for C15H19N5O3: C, 56.77; H, 6.04; N, 22.07. Found: C, 56.97; H, 6.06; N, 21.57. IR (mull): 3251 (m), 3116 (m), 1640 (s), 1598 (s).
Compounds 5
A suspension of 3a-d in EtOH (20-60 mL) was refluxed for 5 h to 4 d. The resulting suspension was filtered and washed with MeCN (4 and 5a), EtOH (4 and 5b and d) or Et2O (4 and 5c) to give a mixture of compounds 4 and 5 in a ratio of 4.5:5.5 (4a:5a), 3:7 (4b:5b), 2.5:7.5 (4c:5c) and 2:8 (4d:5d). The mixture 4a:5a (4.5:5.5) was suspended in H2O and combined with KOH (1 N). The suspension was stirred at r.t. for 45 min to give a 2:8 mixture of 4a:5a. A suspension of these solid mixtures in EtOH (for a and c) or DMF (for b and d) was combined with DBU (1 equiv in relation to the amount of compound 4). The suspension was stirred at 40 °C for 6-18 h (a and b), or at r.t. for 30 min (c and d). The white solid was filtered and washed with EtOH and Et2O to give compound 5a-d. The structure of the products obtained was confirmed by elemental analysis, 1H NMR and 13C NMR spectroscopy.
Characterization of 5a
1H NMR (300 MHz, DMSO-d
6): δ = 8.16 (br s, 2 H), 8.07 (s, 1 H), 7.66 (d, J = 8.7 Hz, 2 H), 7.07 (d, J = 9.0 Hz, 2 H), 3.80 (s, 3 H), 3.36 (s, 3 H). 13C NMR (75 MHz, DMSO-d
6): δ = 158.03, 154.18, 152.39, 151.49, 137.66, 128.13, 124.35, 114.36, 109.00-110.00(br), 55.06, 30.01. Anal. Calcd for C13H13N5O2: C, 57.56; H, 4.83; N, 25.82. Found: C, 57.60; H, 5.06; N, 25.78. IR (mull): 3385 (m), 3208 (s), 3120 (s), 3052 (s), 1883 (w), 1698 (s), 1640 (s), 1601 (s), 1584 (s).
Compounds 4
To a suspension of imidazole 3a-d in MeCN (8-10 mL) was added H2SO4 (1 equiv), and the mixture was refluxed for 18 h to 11 d. The resulting suspension was filtered and washed with MeCN (6a) or EtOH (6b) and Et2O. Then, DBU (1 equiv) was added to a suspension of compound 6a,b in MeCN (3-20 mL). The mixture was stirred at r.t. for 30 min to 3 h, when the white solid was filtered and washed with MeCN and Et2O, to give compounds 4a,b. The structure of the products obtained was confirmed by elemental analysis, 1H NMR and 13C NMR spectroscopy.
Characterization of 4a
1H NMR (300 MHz, DMSO-d
6): δ = 10.70 (v br s, 1 H), 8.08 (s, 1 H), 8.00 (br s, 1 H), 7.64 (d, J = 9.0 Hz, 2 H), 7.08 (d, J = 9.0 Hz, 2 H), 3.80 (s, 3 H), 2.93 (br s, 3 H). The compound 4a was not soluble in DMSO-d
6 and the 13C NMR spectrum was obtained from the salt form. 13C NMR (75 MHz, DMSO-d
6): δ = 160.16, 151.85, 149.94, 141.98, 139.87, 127.31, 125.55, 115.10, 110.62, 55.86, 29.25. Anal. Calcd for C13H13N5O2·0.4H2O: C, 56.07; H, 4.99; N, 25.15. Found: C, 55.95; H, 4.92; N, 25.12. IR (mull): 3234 (s), 3126 (m), 3053 (m), 2733 (m), 1681 (s), 1626 (s), 1596 (s).